Showing results (41-50 of 894) with videos related to

Sort By:
Pageof 90
Cancer Investigation|November 23, 2006
Alemtuzumab in CLL and other lymphoid neoplasmsFarhad Ravandi, Susan O'brien
Leukemia & Lymphoma|April 19, 2019
FLT3 inhibitor quizartinib (AC220)Kiran Naqvi, Farhad Ravandi
Clinical Lymphoma, Myeloma & Leukemia|August 23, 2015
Relapsed Acute Myeloid Leukemia: Need for Innovative Treatment Strategies to Improve OutcomeTalha Badar, Farhad Ravandi
Mayo Clinic Proceedings|December 14, 2005
Chronic lymphoid leukemias other than chronic lymphocytic leukemia: diagnosis and treatmentFarhad Ravandi, Susan O'Brien
Clinical Lymphoma, Myeloma & Leukemia|July 25, 2017
Acute Promyelocytic Leukemia: A PerspectiveFarhad Ravandi, Richard Stone
Cancer Immunology, Immunotherapy : CII|July 19, 2005
Immune defects in patients with chronic lymphocytic leukemiaFarhad Ravandi, Susan O'Brien
Hematology/Oncology Clinics of North America|October 15, 2009
Philadelphia chromosome-positive acute lymphoblastic leukemiaFarhad Ravandi, Partow Kebriaei
Clinical Lymphoma, Myeloma & Leukemia|December 19, 2023
SOHO State of the Art Updates and Next Questions: Oral Therapy in Acute Myeloid LeukemiaPatrice Nasnas, Farhad Ravandi
American Journal of Hematology|December 30, 2017
FLT3 inhibitors in acute myeloid leukemia: Choosing the best when the optimal does not existRita Assi, Farhad Ravandi
Pageof 90